Psychomotor and cognitive functioning in cancer patients

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 1 II, 1997, Pages 159-161

  Sjogren P ^a  

^a Rigshospitalet   (Denmark)

Author keywords

cancer pain; cognitive function; opioids; psychomotor function

Indexed keywords

AMPHETAMINE DERIVATIVE; MORPHINE; OPIATE;

ANALGESIA; CANCER PAIN; COGNITION; CONFERENCE PAPER; DRUG EFFICACY; DRUG TOXICITY; EPIDURAL DRUG ADMINISTRATION; HUMAN; NEUROPATHY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY;

EID: 0031027669     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04631.x     Document Type: Conference Paper

References (17)

1. Haertzen CA, Hooks NT. Changes in personality and subjective experience associated with chronic administration and withdrawal of opioids. J Nerv Ment Dis 1969: 148: 606-614.
2. Kay DC, Pickworth WB, Neidert GL. Morphine-like insomnia from heroin in nondependent human addicts. Br J Clin Pharmacol 1981: 11: 159-169.
3. Kay DC, Eisenstein RB, Jasinski DR. Morphine effects on human REM state, waking state and NREM sleep. Psychopharmacol 1969: 14: 404-416.
4. Banning A, Sjøgren P. Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time. Clin J Pain 1990: 6: 91-95.
5. Sjøgren P, Banning A, Larsen TK, Sørensen CG, Jansen EC. Postural stability during long-term treatment of cancer patients with epidural opioids. Acta Anaesthesiol Scand 1990: 34: 410-412.
6. Banning A, Sjøgren P, Kaiser F. Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids. Acta Anaesthesiol Scand 1992: 36: 480-482.
7. Bruera E, MacMillan K, Hanson J, MacDonald RN. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989:39: 13-16.
8. Sjøgren P, Banning A. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids. Pain 1989: 39: 5-11.
9. Sjøgren P, Banning A, Christensen CB, Pedersen O. Continuous reaction time after single dose, long-term oral and epidural opioid administration. Eur J Anaesthesiol 1994: 11: 95-100.
10. Wood MM, Ashby M, Flemming B, Somogyi A. The neuropsychological correlates of high morphine plasma correlations in terminally ill patients. 7th World Congress on Pain 1993. Abstract no. 465.
11. Westerling D, Frigren L, Höglund P. Morphine pharmacokinetics and effects on salivation and continuous reaction time in healthy volunteers. Ther Drug Monit 1993: 15: 364-374.
12. Bruera E, Carraro S, Roca E, Barugel M, Chacon R. Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients. Cancer Treat Rep 1986: 70: 295-298.
13. Bruera E, Chadwick S, Brenneis C, Hanson J, MacDonald RN. Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 1987: 71: 67-70.
14. Bruera E, Miller MJ, MacMillan K, Kuehn N. Neurophysiological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 1992: 48: 163-166.
15. Portenoy R, Hagen N. Breakthrough pain: definition, prevalence and characteristics. Pain 1990: 41: 273-283.
16. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988: 33: 11-23.
17. Bruera E, Fainsinger R, MacEackern T, Hanson J. The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. Pain 1992: 50: 75-77.